Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v2-EN
Language English English
Date Updated 2022-06-22 2021-05-12
Drug Identification Number 02441691 02441691
Brand name PRISM0CAL B22K0/0 PRISM0CAL B22K0/0
Common or Proper name PRISM0CAL B22K0/0 PRISM0CAL B22K0/0
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients SODIUM BICARBONATE SODIUM CHLORIDE MAGNESIUM CHLORIDE SODIUM BICARBONATE SODIUM CHLORIDE MAGNESIUM CHLORIDE
Strength(s) 2.12G 7.14G 3.05G 2.12G 7.14G 3.05G
Dosage form(s) SOLUTION SOLUTION
Route of administration DIALYSIS INTRAVENOUS DIALYSIS INTRAVENOUS DIALYSIS INTRAVENOUS DIALYSIS INTRAVENOUS
Packaging size 5L Bags (Product Code 115295) 5L Bags (Product Code 115295)
ATC code B05ZB B05ZB
ATC description HEMODIALYTICS AND HEMOFILTRATES HEMODIALYTICS AND HEMOFILTRATES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2021-07-11 2021-07-11
Actual start date 2021-07-11
Estimated end date 2022-06-20 Unknown
Actual end date 2022-06-20
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments PrismaSOL 0 (113881)/ PrismaSOL 4 (113883)/ Prism0CAL (113884) / Prism0CAL B22 (115295) CRRT Solution is currently on 75% allocation, which means that 75% of a customer’s historic monthly demand would be automatically fulfilled. Any orders above this amount would require a customer to request an additional release through our customer care team for consideration. Demand for this product remains high, thus posing a risk for intermittent branch-level and/or national back orders over the next 2-4 months. PrismaSOL 0 (113881)/ PrismaSOL 4 (113883)/ Prism0CAL (113884) / Prism0CAL B22 (115295) CRRT Solution is currently on 75% allocation, which means that 75% of a customer’s historic monthly demand would be automatically fulfilled. Any orders above this amount would require a customer to request an additional release through our customer care team for consideration. Demand for this product remains high, thus posing a risk for intermittent branch-level and/or national back orders over the next 2-4 months.
Health Canada comments